1887

Abstract

Outbreaks of porcine circovirus (PCV) type 2 (PCV2)-associated diseases have caused substantial economic losses worldwide in the last 20 years. The PCV capsid protein (Cap) is the sole structural protein and main antigenic determinant of this virus. In this study, not only were phylogenetic trees reconstructed, but variations of surface structure of the PCV capsid were analysed in the course of evolution. Unique surface patterns of the icosahedral fivefold axes of the PCV2 capsid were identified and characterized, all of which were absent in PCV type 1 (PCV1). Icosahedral fivefold axes, decorated with Loops BC, HI and DE, were distinctly different between PCV2 and PCV1. Loops BC, determining the outermost surface around the fivefold axes of PCV capsids, had limited homology between Caps of PCV1 and PCV2. A conserved tyrosine phosphorylation motif in Loop HI that might be recognized by non-receptor tyrosine kinase(s) was present only in PCV2. Particularly, the concurrent presence of 60 pairs of the conserved tyrosine and a canonical PXXP motif on the PCV2 capsid surface could be a mechanism for PXXP motif binding to and activation of an SH3-domain-containing tyrosine kinase in host cells. Additionally, a conserved cysteine in Loop DE of the PCV2 Cap was substituted by an arginine in PCV1, indicating potentially distinct assembly mechanisms of the capsid between PCV1 and PCV2. Therefore, these unique patterns on the PCV2 capsid surface, absent in PCV1 isolates, might be related to cell entry, virus function and pathogenesis.

Keyword(s): Capsid and Surface structure
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000634
2016-12-16
2019-12-15
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/12/3331.html?itemId=/content/journal/jgv/10.1099/jgv.0.000634&mimeType=html&fmt=ahah

References

  1. Alarcon P., Rushton J., Wieland B.. 2013; Cost of post-weaning multi-systemic wasting syndrome and porcine circovirus type-2 subclinical infection in England – an economic disease model. Prev Vet Med110:88–102 [CrossRef][PubMed]
    [Google Scholar]
  2. An D. J., Roh I. S., Song D. S., Park C. K., Park B. K.. 2007; Phylogenetic characterization of porcine circovirus type 2 in PMWS and PDNS Korean pigs between 1999 and 2006. Virus Res129:115–122[CrossRef]
    [Google Scholar]
  3. Backert S., Feller S. M., Wessler S.. 2008; Emerging roles of Abl family tyrosine kinases in microbial pathogenesis. Trends Biochem Sci33:80–90 [CrossRef][PubMed]
    [Google Scholar]
  4. Biasini M., Bienert S., Waterhouse A., Arnold K., Studer G., Schmidt T., Kiefer F., Gallo Cassarino T., Bertoni M. et al. 2014; SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res42:W252–W258 [CrossRef][PubMed]
    [Google Scholar]
  5. Blanchard P., Mahé D., Cariolet R., Keranflec'h A., Baudouard M. A., Cordioli P., Albina E., Jestin A.. 2003; Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins. Vaccine21:4565–4575 [CrossRef][PubMed]
    [Google Scholar]
  6. Cai L., Ni J., Xia Y., Zi Z., Ning K., Qiu P., Li X., Wang B., Liu Q. et al. 2012; Identification of an emerging recombinant cluster in porcine circovirus type 2. Virus Res165:95–102[CrossRef]
    [Google Scholar]
  7. Case D. A., Cheatham T. E. 3rd, Darden T., Gohlke H., Luo R., Merz K. M., Onufriev A., Simmerling C., Wang B., Woods R. J.. 2005; The Amber biomolecular simulation programs. J Comput Chem26:1668–1688 [CrossRef][PubMed]
    [Google Scholar]
  8. Cheung A. K.. 2003; The essential and nonessential transcription units for viral protein synthesis and DNA replication of porcine circovirus type 2. Virology313:452–459 [CrossRef][PubMed]
    [Google Scholar]
  9. Cheung A. K., Greenlee J. J.. 2011; Identification of an amino acid domain encoded by the capsid gene of porcine circovirus type 2 that modulates intracellular viral protein distribution during replication. Virus Res155:358–362 [CrossRef][PubMed]
    [Google Scholar]
  10. Cheung A. K., Lager K. M., Kohutyuk O., Vincent A. L., Henry S. C., Baker R. B., Rowland R. R., Dunham A. G.. 2007; Detection of two porcine circovirus type 2 genotypic groups in United States swine herds. Arch Virol152:1035–1044 [CrossRef][PubMed]
    [Google Scholar]
  11. Cortey M., Olvera A., Grau-Roma L., Segalés J.. 2011; Further comments on porcine circovirus type 2 (PCV2) genotype definition and nomenclature. Vet Microbiol149:522–523 [CrossRef][PubMed]
    [Google Scholar]
  12. Doster A. R., Subramaniam S., Yhee J. Y., Kwon B. J., Yu C. H., Kwon S. Y., Osorio F. A., Sur J. H.. 2010; Distribution and characterization of IL-10-secreting cells in lymphoid tissues of PCV2-infected pigs. J Vet Sci11:177–183 [CrossRef][PubMed]
    [Google Scholar]
  13. Du Q., Huang Y., Wang T., Zhang X., Chen Y., Cui B., Li D., Zhao X., Zhang W. et al. 2016; Porcine circovirus type 2 activates PI3K/Akt and p38 MAPK pathways to promote interleukin-10 production in macrophages via Cap interaction of gC1qR. Oncotarget7:17492–17507 [CrossRef][PubMed]
    [Google Scholar]
  14. Fachinger V., Bischoff R., Jedidia S. B., Saalmüller A., Elbers K.. 2008; The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex. Vaccine26:1488–1499 [CrossRef][PubMed]
    [Google Scholar]
  15. Fenaux M., Opriessnig T., Halbur P. G., Xu Y., Potts B., Meng X. J.. 2004; Detection and in vitro and in vivo characterization of porcine circovirus DNA from a porcine-derived commercial pepsin product. J Gen Virol85:3377–3382 [CrossRef][PubMed]
    [Google Scholar]
  16. Finsterbusch T., Mankertz A.. 2009; Porcine circoviruses–small but powerful. Virus Res143:177–183 [CrossRef][PubMed]
    [Google Scholar]
  17. Franzo G., Cortey M., Segalés J., Hughes J., Drigo M.. 2016; Phylodynamic analysis of porcine circovirus type 2 reveals global waves of emerging genotypes and the circulation of recombinant forms. Mol Phylogenet Evol100:269–280 [CrossRef][PubMed]
    [Google Scholar]
  18. Gillespie J., Opriessnig T., Meng X. J., Pelzer K., Buechner-Maxwell V.. 2009; Porcine circovirus type 2 and porcine circovirus-associated disease. J Vet Intern Med23:1151–1163[CrossRef]
    [Google Scholar]
  19. Grau-Roma L., Crisci E., Sibila M., López-Soria S., Nofrarias M., Cortey M., Fraile L., Olvera A., Segalés J.. 2008; A proposal on porcine circovirus type 2 (PCV2) genotype definition and their relation with postweaning multisystemic wasting syndrome (PMWS) occurrence. Vet Microbiol128:23–35 [CrossRef][PubMed]
    [Google Scholar]
  20. Greenidge P. A., Kramer C., Mozziconacci J. C., Wolf R. M.. 2013; MM/GBSA binding energy prediction on the PDBbind data set: successes, failures, and directions for further improvement. J Chem Inf Model53:201–209 [CrossRef][PubMed]
    [Google Scholar]
  21. Horlen K. P., Dritz S. S., Nietfeld J. C., Henry S. C., Hesse R. A., Oberst R., Hays M., Anderson J., Rowland R. R.. 2008; A field evaluation of mortality rate and growth performance in pigs vaccinated against porcine circovirus type 2. J Am Vet Med Assoc232:906–912[CrossRef]
    [Google Scholar]
  22. Hua T., Wang X., Bai J., Zhang L., Liu J., Jiang P.. 2013; Attenuation of porcine circovirus type-2b by replacement with the Rep gene of porcine circovirus type-1. Virus Res173:270–279 [CrossRef][PubMed]
    [Google Scholar]
  23. Huang L. P., Lu Y. H., Wei Y. W., Guo L. J., Liu C. M.. 2011; Identification of one critical amino acid that determines a conformational neutralizing epitope in the capsid protein of porcine circovirus type 2. BMC Microbiol11:188 [CrossRef][PubMed]
    [Google Scholar]
  24. Humphrey W., Dalke A., Schulten K.. 1996; VMD: visual molecular dynamics. J Mol Graph14:33–38 [CrossRef][PubMed]
    [Google Scholar]
  25. Juhan N. M., LeRoith T., Opriessnig T., Meng X. J.. 2010; The open reading frame 3 (ORF3) of porcine circovirus type 2 (PCV2) is dispensable for virus infection but evidence of reduced pathogenicity is limited in pigs infected by an ORF3-null PCV2 mutant. Virus Res147:60–66 [CrossRef][PubMed]
    [Google Scholar]
  26. Kekarainen T., Montoya M., Mateu E., Segalés J.. 2008; Porcine circovirus type 2-induced interleukin-10 modulates recall antigen responses. J Gen Virol89:760–765 [CrossRef][PubMed]
    [Google Scholar]
  27. Khayat R., Brunn N., Speir J. A., Hardham J. M., Ankenbauer R. G., Schneemann A., Johnson J. E.. 2011; The 2.3-angstrom structure of porcine circovirus 2. J Virol85:7856–7862[CrossRef]
    [Google Scholar]
  28. Lekcharoensuk P., Morozov I., Paul P. S., Thangthumniyom N., Wajjawalku W., Meng X. J.. 2004; Epitope mapping of the major capsid protein of type 2 porcine circovirus (PCV2) by using chimeric PCV1 and PCV2. J Virol78:8135–8145[CrossRef]
    [Google Scholar]
  29. Liu J., Chen I., Kwang J.. 2005; Characterization of a previously unidentified viral protein in porcine circovirus type 2-infected cells and its role in virus-induced apoptosis. J Virol79:8262–8274 [CrossRef][PubMed]
    [Google Scholar]
  30. Liu L. J., Suzuki T., Tsunemitsu H., Kataoka M., Ngata N., Takeda N., Wakita T., Miyamura T., Li T. C.. 2008; Efficient production of type 2 porcine circovirus-like particles by a recombinant baculovirus. Arch Virol153:2291–2295 [CrossRef][PubMed]
    [Google Scholar]
  31. Liu J., Huang L., Wei Y., Tang Q., Liu D., Wang Y., Li S., Guo L., Wu H., Liu C.. 2013; Amino acid mutations in the capsid protein produce novel porcine circovirus type 2 neutralizing epitopes. Vet Microbiol165:260–267 [CrossRef]
    [Google Scholar]
  32. Liu Z., Guo F., Wang F., Li T. C., Jiang W.. 2016; 2.9 Å Resolution cryo-EM 3D reconstruction of close-packed virus particles. Structure24:319–328 [CrossRef][PubMed]
    [Google Scholar]
  33. Misinzo G., Meerts P., Bublot M., Mast J., Weingartl H. M., Nauwynck H. J.. 2005; Binding and entry characteristics of porcine circovirus 2 in cells of the porcine monocytic line 3D4/31. J Gen Virol86:2057–2068 [CrossRef][PubMed]
    [Google Scholar]
  34. Misinzo G., Delputte P. L., Meerts P., Lefebvre D. J., Nauwynck H. J.. 2006; Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate B glycosaminoglycans as receptors for its attachment to host cells. J Virol80:3487–3494 [CrossRef][PubMed]
    [Google Scholar]
  35. Misinzo G., Delputte P. L., Lefebvre D. J., Nauwynck H. J.. 2009; Porcine circovirus 2 infection of epithelial cells is clathrin-, caveolae- and dynamin-independent, actin and Rho-GTPase-mediated, and enhanced by cholesterol depletion. Virus Res139:1–9 [CrossRef][PubMed]
    [Google Scholar]
  36. Mu C., Yang Q., Zhang Y., Zhou Y., Zhang J., Martin D. P., Xia P., Cui B.. 2012; Genetic variation and phylogenetic analysis of porcine circovirus type 2 infections in central China. Virus Genes45:463–473 [CrossRef][PubMed]
    [Google Scholar]
  37. Nauwynck H. J., Sanchez R., Meerts P., Lefebvre D. J., Saha D., Huang L., Misinzo G.. 2012; Cell tropism and entry of porcine circovirus 2. Virus Res164:43–45[CrossRef]
    [Google Scholar]
  38. Nawagitgul P., Morozov I., Bolin S. R., Harms P. A., Sorden S. D., Paul P. S.. 2000; Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein. J Gen Virol81:2281–2287 [CrossRef][PubMed]
    [Google Scholar]
  39. Olvera A., Cortey M., Segalés J.. 2007; Molecular evolution of porcine circovirus type 2 genomes: phylogeny and clonality. Virology357:175–185 [CrossRef][PubMed]
    [Google Scholar]
  40. Opriessnig T., Xiao C. T., Gerber P. F., Halbur P. G., Matzinger S. R., Meng X. J.. 2014; Mutant USA strain of porcine circovirus type 2 (mPCV2) exhibits similar virulence to the classical PCV2a and PCV2b strains in caesarean-derived, colostrum-deprived pigs. J Gen Virol95:2495–2503 [CrossRef][PubMed]
    [Google Scholar]
  41. Pagano M. A., Tibaldi E., Palù G., Brunati A. M.. 2013; Viral proteins and Src family kinases: mechanisms of pathogenicity from a "liaison dangereuse". World J Virol2:71–78 [CrossRef][PubMed]
    [Google Scholar]
  42. Pogranichnyy R. M., Yoon K. J., Harms P. A., Swenson S. L., Zimmerman J. J., Sorden S. D.. 2000; Characterization of immune response of young pigs to porcine circovirus type 2 infection. Viral Immunol13:143–153 [CrossRef][PubMed]
    [Google Scholar]
  43. Reiner G., Hofmeister R., Willems H.. 2015; Genetic variability of porcine circovirus 2 (PCV2) field isolates from vaccinated and non-vaccinated pig herds in Germany. Vet Microbiol180:41–48 [CrossRef][PubMed]
    [Google Scholar]
  44. Saksela K.. 2011; Interactions of the HIV/SIV pathogenicity factor Nef with SH3 domain-containing host cell proteins. Curr HIV Res9:531–542 [CrossRef][PubMed]
    [Google Scholar]
  45. Segalés J., Olvera A., Grau-Roma L., Charreyre C., Nauwynck H., Larsen L., Dupont K., McCullough K., Ellis J. et al. 2008; PCV-2 genotype definition and nomenclature. Vet Rec162:867–868 [CrossRef][PubMed]
    [Google Scholar]
  46. Segalés J., Kekarainen T., Cortey M.. 2013; The natural history of porcine circovirus type 2: from an inoffensive virus to a devastating swine disease?. Vet Microbiol165:13–20 [CrossRef]
    [Google Scholar]
  47. Seo H. W., Han K., Park C., Chae C.. 2014a; Clinical, virological, immunological and pathological evaluation of four porcine circovirus type 2 vaccines. Vet J200:65–70 [CrossRef]
    [Google Scholar]
  48. Seo H. W., Park C., Kang I., Choi K., Jeong J., Park S. J., Chae C.. 2014b; Genetic and antigenic characterization of a newly emerging porcine circovirus type 2b mutant first isolated in cases of vaccine failure in Korea. Arch Virol159:3107–3111 [CrossRef]
    [Google Scholar]
  49. Shang S. B., Jin Y. L., Jiang X. T., Zhou J. Y., Zhang X., Xing G., He J. L., Yan Y.. 2009; Fine mapping of antigenic epitopes on capsid proteins of porcine circovirus, and antigenic phenotype of porcine circovirus type 2. Mol Immunol46:327–334[CrossRef]
    [Google Scholar]
  50. Songyang Z., Carraway K. L., Eck M. J., Harrison S. C., Feldman R. A., Mohammadi M., Schlessinger J., Hubbard S. R., Smith D. P. et al. 1995; Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature373:536–539 [CrossRef][PubMed]
    [Google Scholar]
  51. Suomalainen M., Greber U. F.. 2013; Uncoating of non-enveloped viruses. Curr Opin Virol3:27–33 [CrossRef][PubMed]
    [Google Scholar]
  52. Tischer I., Rasch R., Tochtermann G.. 1974; Characterization of papovavirus-and picornavirus-like particles in permanent pig kidney cell lines. Zentralbl Bakteriol Orig A226:153–167[PubMed]
    [Google Scholar]
  53. van den Berg A., Dowdy S. F.. 2011; Protein transduction domain delivery of therapeutic macromolecules. Curr Opin Biotechnol22:888–893 [CrossRef][PubMed]
    [Google Scholar]
  54. Wang C., Pang V. F., Lee F., Huang T. S., Lee S. H., Lin Y. J., Lin Y. L., Lai S. S., Jeng C. R.. 2013; Prevalence and genetic variation of porcine circovirus type 2 in Taiwan from 2001 to 2011. Res Vet Sci94:789–795[CrossRef]
    [Google Scholar]
  55. Wei C., Zhang M., Chen Y., Xie J., Huang Z., Zhu W., Xu T., Cao Z., Zhou P. et al. 2013; Genetic evolution and phylogenetic analysis of porcine circovirus type 2 infections in southern China from 2011 to 2012. Infect Genet Evol17:87–92 [CrossRef][PubMed]
    [Google Scholar]
  56. Wu P. C., Lin W. L., Wu C. M., Chi J. N., Chien M. S., Huang C.. 2012; Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development. Appl Microbiol Biotechnol95:1501–1507 [CrossRef][PubMed]
    [Google Scholar]
  57. Xiao C. T., Halbur P. G., Opriessnig T.. 2012; Complete genome sequence of a novel porcine circovirus type 2b variant present in cases of vaccine failures in the United States. J Virol86:12469 [CrossRef][PubMed]
    [Google Scholar]
  58. Yamauchi Y., Helenius A.. 2013; Virus entry at a glance. J Cell Sci126:1289–1295 [CrossRef][PubMed]
    [Google Scholar]
  59. Zhan Y., Wang N., Zhu Z., Wang Z., Wang A., Deng Z., Yang Y.. 2016; In silico analyses of antigenicity and surface structure variation of an emerging porcine circovirus genotype 2b mutant, prevalent in southern China from 2013 to 2015. J Gen Virol97:922–933 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000634
Loading
/content/journal/jgv/10.1099/jgv.0.000634
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error